The impact of the type 1 and type 2 T Helper cell concept on novel vaccine design with emphasis on protection against Leishmania Parasites

Concepts in Vaccine Development

Volumn , Issue , 2012, Pages 205-242

  Bogdan, Christian ^a   Röllinghoff, Martin ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85064855909     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (225)

1. Aebischer, T., Morris, L., and Handman, E. (1994) Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance. Int. Immunol. 6, 1535-1543
2. Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G., and Scott, P. (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237
3. Akuffo, H. O., Fehninger, T. E., and Britton, S. (1984) Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. J. Immunol. 141, 2461-2466
4. Antunes, C. M., Mayrink, W., Magalhaes, P. A., Costa, C. A., Melo, M. N., Dias, M., Michalick, M. S., Williams, P., Lima, A. O., and Vieira, J. B. (1986) Controlled field trials of a vaccine against New World cutaneous leishmaniasis. Int. J. Epidemiol. 15, 572-580
5. Badaró, R. and Johnson, W. D. (1993) The role of interferon-β in the treatment of visceral and diffuse cutaneous leishmaniasis. J. Infect. Dis. 167, S13-17
6. Barral-Netto, M., Barrai, A., Brownell, C. E., Skeiky, Y. A. W., Ellingsworth, L. R, Twardzik, D. R. and Reed, S. G. (1992) Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257, 545-548
7. Bates, P. A. (1995) The lipophosphoglycan-associated molecules of Leishmania. Parasitol. Today 77, 317-318
8. Belosevic, M., Finbloom, D. S, van der Meide, P. H., Slayter, M. V., and Nacy, C. A. (1989) Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143, 266-274
9. Bendelac, A. (1995) CD1: presenting unusual antigens to unusual T lymphocytes. Science 269, 185-186
10. Biron, C. A. and Gazzinelli, R. T. (1995) Effects of IL-12 in immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7, 485-496
11. Blackwell, J. M, Barton, C. H., White, J. K, Roach, T. I. A., Shaw, M.-A., Whitehead, S. H., Mock, B. A., Searle, S., Williams, H., and Baker, A.-M. (1994) Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Letters 43, 99-107
12. Blackwell, J. M., Roberts, B., and Alexander, J. (1985) Response of BALB/c mice to leishmanial infection. Curr. Top. Microbiol. Immunol. 722, 97-106
13. Bogdan, C. and Nathan, C. (1993) Modulation of macrophage function by transforming growth factor-β, interleukin 4 and interleukin 10. Ann. NY. Acad. Sci. 685, 713-739
14. Bogdan, C., Gessner, A., and Röllinghoff, M. (1993) Cytokines in Leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiol. 189, 356-396
15. Bogdan, C, Schröppel, K, Lohoff, M, Röllinghoff, M., and Solbach, W. (1990) Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells. Eur. J. Immunol. 20, 2533-2540
16. Bogdan, C., Vodovotz, Y., Paik, J., Xie, Q.-W, and Nathan, C. (1994) Mechanism of suppression of nitric oxide synthase expression by interleukin 4 in primary mouse macrophages. J. Leukoc. Biol. 55, 227-233
17. Boom, W. H., Liebster, L., Abbas, A. K., and Titus, R. G. (1990) Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun. 58, 3863-3870
18. Bretscher, P. A., Wei, G., Menon, J. N., and Bielefeldt-Ohmann, H. (1992) Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 257, 539-542
19. Cabrera, M., Shaw, M.-A., Sharpies, C., Williams, H., Castes, M., Convit, J., and Blackwell, J. M. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182, 1259-1264
20. Cáceres-Dittmar, G., Tapia, F. J., Sánchez, M. A., Yamamura, M., Uyemura, K., Modlin, R. L., Bloom, B. R., and Convit, J. (1993) Determination of the cytokine profile in american cutaneous leishmaniasis using the polymerase chain reaction. Clin. Exp. Immunol. 91, 500-505
21. Campos-Neto, A., Soong, L., Cordova, J. L., Sant'Angelo, D., Skeiky, Y. A. W., Ruddle, N. H., Reed, S. G., Janeway, C., and McMahon-Pratt, D. (1995) Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J. Exp. Med. 182, 1423-1433
22. Carvalho, E. M, Bacellar, O., Brownell, C, Regis, T., Coffman, R. L, and Reed, S. L. (1994) Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152, 5949-5956
23. Carvalho, E. M, Badaro, R., Reed, S. G, Jones, T. C., and Johnson, W. D. (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76, 2066-2069
24. Castés, M., Agnelli, A., and. Rondón, A. J (1984) Mechanisms associated with immunoregulation in human american cutaneous leishmaniasis. Clin. Exp. Immunol. 57, 279-286
25. Chakkalath, H. R. and Titus, R. G. (1994) Leishmania mayor-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 153, 4378-87
26. Chakkalath, H. R., Theodos, C. M., Markowitz, J. S., Grusby, M. J., Glimcher, L. H., and Titus, R. G. (1995) Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J. Inf. Dis. 171, 1302-1308
27. Coffman, R. L., Seymour, B. W., Lebman, D. A., Hiraki, D. D., Christiansen, J. A., Shrader, B., Cherwinski, H. M., Savelkoul, H. F., Finkelman, F. D., Bond, M. W., and Mosmann, T. R. (1988) The role of helper T cell products in mouse T cell differentiation and isotype regulation. Immunol. Rev. 102, 5
28. Connell, N. D., Medina-Acosta, E, McMaster, R. W., Bloom, B. R, and Russell, D. G. (1993) Effective immunization against cutaneous leishmaniasis with recombinant bacille-Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90, 11473-11477
29. Constant, S, Pfeiffer, C., Woodard, A., Pasqualini, T., and Bottomly, K. (1995) Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182, 1591-1596
30. Corry, D. B., Reiner, S. L., Linsley, P. S., and Locksley, R. M. (1994) Differential effects of blockade of CD28-B7 on the development of Th 1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153, 4142-4148
31. Croft, M., Carter, L., Swain, S. L., and Dutton, R. W. (1994) Generation of polarized antigenspecific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180, 1715-1728
32. Cruz, A. K., Titus, R., and Beverley, S. M. (1993) Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. Proc. Natl. Acad. Sci. USA 90, 1599-1603
33. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., and Trinchieri, G. (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048
34. del Prete, G., de Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., and Romagnani, S. (1993) Human IL-10 is produced by both type 1 helper (Thl) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150: 353-360
35. Di Marzio, P., Puddu, P., Conti, L., Belardelli, F., and Gessani, S. (1994) Interferon-γ upregulates its own gene expression in mouse peritoneal macrophages. J. Exp. Med. 179, 1731-1736
36. Doherty, T. M. and Coffman, R. L. (1993) Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 150, 5476-5483
37. Else, K. J., Finkelman, F. D., Maliszewski, C. R., and Grencis, R. K. (1994) Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med. 179, 347-351
38. Erard, F. and Le Gros, G. (1994) Th2-like CD8 T cells: their role in protection against infectious diseases. Parasitol. Today 10, 313-315
39. Evans, T. G., Teixeira, M. J., McAuliffe, I. T., de Alencar Barros Vasconcelos, I., Vasconcelos, A. W., de Queiroz Sousa, A., de Oliveira Lima, J. W., and Pearson, R. D. (1992) Epidemiology of visceral leishmaniasis in northeast Brazil. J. Infect. Dis. 166, 1124-1132
40. Evavold, B. D, Sloan-Lancaster, J., and Allen, P. M. (1993) Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14, 602-609
41. Farrell, J. P., Müller, I., and Louis, J. A. (1989) A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice. J. Immunol. 142, 2052-2056
42. Ferrick, D. A., Schrenzel, M. D., Mulvania, T., Hsieh, B., Ferlin, W. G., and Lepper, H. (1995) Differential production of interferon-γ and interleukin-4 in response to Thl-and Th2-stimulating pathogens by γδ T cells in vivo. Nature 373, 255-257
43. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J. Exp. Med. 170, 2081-2095
44. Firestein, G. S., Roeder, W. D., Laxer, J. A., Townsend, K. S., Weaver, C. T., Horn, J. T., Linton, J., Torbett, B. E., and Glasebrook, A. L. (1989) A new murine CD4+ T cell subset with an unrestricted cytokine profile. J. Immunol. 143, 518-525
45. Fitch, F. W., McKisic, M. D., Lancki, D. W., and Gajewski, T. F. (1993) Differential regulation of murine T lymphocyte subsets. Ann. Rev. Immunol. 11, 29-48
46. Frommel, D., Ogunkolade, B. W., Vouldoukis, I., and Monjour, L. (1988) Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice. Infect. Immun. 56, 843-848
47. Fultz, M. J., Barber, S. A., Dieffenbach, C. W., and Vogel, S. N. (1993) Induction of IFN-γ in macrophages by lipopolysaccharide. Int. Immunol. 5, 1383-1392
48. Gaadar, A., Kharazmi, A., Ismail, A., Kemp, A., Hey, A., Christensen, C. B. V., Dafalla, M., El Kadaro, A. Y., El Hassan, A. M., and Theander, T. G. (1995) Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Thl activity is associated with severe infections. Clin. Exp. Immunol. 100, 239-245
49. Garcia, I., Miyazaki, Y., Araki, K., Lucas, R., Grau, G. E., Milon, G., Belkaid, Y., Montixi, C., Lesslauer, W., and Vassalli, R (1995) Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25, 2401-2407
50. Gately, M. K., Warner, R. R., Honasoge, S., Carvajal, D. M., Faherty, D. A., Connaughton, S. E., Anderson, T. D., Sarmiento, U., Hubbard, B. R. and Murphy, M. (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γB vivo. Int. Immunol. 6, 157-167
51. Germann, T. and Rüde, E. (1995) Interleukin 12. Int. Arch. Allergy Immunol. 108, 103-112
52. Germann, T., Mattner, F., Partenheimer, A., Schmitt, E., Reske-Kunz, A. B., Fischer, H.-G., and Rüde, E. (1992) Different accessory function for Thl cells of bone marrow derived macrophages cultured in granulocyte macrophage colony stimulating factor or macrophage colony stimulating factor. Int. Immunol. 4, 755-764
53. Ghalib, H. W, Piuvezam, M. R, Skeiky, Y. A. W, Siddig, M, Hashim, F. A., El-Hassan, A. M, Russo, D. M., and Reed, S. G. (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92, 324-329
54. Ghalib, H. W., Whittle, J. A., Kubin, M., Hashim, F. A., El-Hassan, A. M., Grabstein, K. H., Trinchieri, G., and Reed, S. G. (1995) IL-12 enhances Thl-type responses in human Leishmania donovani infections. J. Immunol. 154, 4623-4629
55. Gordon, J. R., Burd, P. R., and Galli, S. J. (1990) Mast cells as a source of multifunctional cytokines. Immunol. Today 11, 458-464
56. Greenblatt, C. L. (1988) Cutaneous Leishmaniasis: the prospects for a killed vaccine. Parasitol. Today 4, 53-54
57. Handman, E., Symons, F. M, Baldwin, T. M, Curtis, J. M., and Scheerlinck, J.-P. Y. (1995) Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a Thl type of immune response. Infect. Immun. 63, 4261-4267
58. Heinzel, F. P., Sadick, M. D, Holaday, B. J., Coffman, R. L, and Locksley, R. M. (1989) Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72
59. Heinzel, F. P., Sadick, M. D., Mutha, S. S., and Locksley, R. M. (1991) Production of interferon-γ, interleukin 2, interleukin 4 and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88, 7011-7015
60. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E, and Gately, M. K. (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509
61. Hey, A. S., Theander, T. G., Hviid, L., Hazrati, S. M, Kemp, M, and Kharazmi, A. (1994) The major surface glycoprotein (gp63) from Leishmania major and Leishmania donovani cleaves CD4 molecules on human T cells. J. Immunol. 152, 4542-4548
62. Hill, J. O., Awwad, M., and North, R. J. (1989) Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania. J. Exp. Med. 169, 1819-1827
63. Holaday, B. J., de Lima Pompeu, M. M., Jeronimo, S., Texeira, M. J., de Queiroz Sousa, A., Vasconcelos, A. W., Pearson, R. D., Abrams, J. S., and Locksley, R. M. (1993) Potential role for interleukin-10 in the immunosuppression associated with kala-azar. J. Clin. Invest. 92, 2626-2632
64. Hosken, N. A., Shibuya, K, Heath, A. W, Murphy, K. M, and O'Garra, A. (1995) The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell-receptor-aβtransgenic model. J. Exp. Med. 182, 1579-1584
65. Howard, J. G., Hale, C., and Chan-Liew, W. L. (1980) Immunological regulation of experimental cutaneous leishmaniasis. I. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 2, 303-314
66. Howard, J. G., Hale, C., and Liew, F. Y. (1980) Genetically determined susceptibility to Leishmania tropica infection is expressed by haematopoietic donor cells in mouse radiation chimeras. Nature 288, 161-162
67. Howard, J. G., Liew, F. Y., Hale, C., and Nickiin, S. (1984) Prophylactic immunization against experimental leishmaniasis II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J. Immunol. 132, 450-455
68. Hsieh, C.-S., Macatonia, S. E., O'Garra, A., and Murphy, K. M. (1993) Pathogen-induced Thl phenotype development in CD4+ αβ-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5, 371-382
69. Hsieh, C.-S., Macatonia, S. E., O'Garra, A., and Murphy, K. M. (1995) T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181, 713-721
70. Huels, C., Germann, T., Giedert, S., Hoehn, P., Koelsch, S., Hiiltner, L., Palm, N., Rüde, E., and Schmitt, E. (1995) Co-activation of naive CD4+ T cells and bone marrow-derived mast cells results in the development of Th2 cells. Int. Immunol. 7, 525-532
71. Jardim, P., Alexander, J., Teh, H. S., Ou, D., and Olafson, R. W. (1990) Immunoprotective Leishmania major synthetic T cell epitopes. J. Exp. Med. 172, 645-648
72. Jarecki-Black, J. C., James, E. R., Kirshtein, J. W., Kirshtein, J. D., and Glassman, A. B. (1986) Leishmania donovani: immunization against infection as a function of parasite growth phase. Am. J. Trop. Med. Hyg. 35, 1117-1120
73. Jeannin, P., Delneste, Y., Life, P., Gauchat, J.-F., Kaiserlian, D, and Bonnefoy, J.-Y. (1995) Interleukin-12 increases interleukin-4 production by established human ThO and Th2-like T cell clones. Eur. J. Immunol. 25, 2247-2252
74. Joshi, M., Dwyer, D. M., and Nakhasi, H. L. (1993) Cloning and characterization of differentially expressed genes from in vitro-grown 'amastigotes' of Leishmania donovani. Mol. and Biochem. Parasitol. 58, 345-354
75. Kahl, L. P., Lelchuk, R., Scott, C. A., and Beesley, J. (1990) Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis. Infect. Immun. 58, 3233-3241
76. Kamogawa, Y., Minasi, L.-A. E., Carding, S. R., Bottomly, K, and Flavell, R. (1993) The relationship of IL-4-and IFN-y-producing T cells studied by lineage ablation of IL-4 producing cells. Cell 75, 985-995
77. Karp, C. L, El-Safi, S. H, Wynn, T. A., Satti, M. M. H., Kordofani, A. M., Hashim, F. A., Hag-Ali, M., Neva, F. A., Nutman, T. B., and Sacks, D. L. (1993) In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-g. J. Clin. Invest. 91, 1644-1648
78. Katzenellenbogen, I. (1944) Vaccination against oriental sore. Report of results of five hundred and fifty-five inoculations. Arch. Dermatol. Syph. 50, 239-242
79. Kaye, P. M, Curry, A. J., and Blackwell, J. M. (1991) Differential production of Thl-and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146, 2763-2770
80. Kaye, R M., Rogers, N. J., Curry, A. J., and Scott, J. C. (1994) Deficient expression of costimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol. 24, 2850-2854
81. Kelleher, M., Moody, S. F., Mirabile, P., Osborn, A. H., Bacic, A., and Handman, E. (1995) Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. Infect. Immun. 63, 43-50
82. Kelso, A. (1995) Thl and Th2 subsets: paradigms lost? Immunol. Today 16, 374-379
83. Kelso, A. and Gough, N. M. (1988) Coexpression of granulocyte-macrophage colonystimulating factor, γ interferon, and interleukin 3 and 4 is random in murine alloreactive Tlymphocyte clones. Proc. Natl. Acad. Sci. USA 85, 9189-9193
84. Kemp, M., Hey, A. S., Kurtzhals, J. A. L., Christensen, C. B. V., Gaafar, A., Mustafa, M. D., Kordofani, A. A. Y., Ismail, A., Kharazmi, A., and Theander, T. G. (1994) Dichotomy of the human T cell response to Leishmanial antigens. I. Thl-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin. Exp. Immunol. 96, 410-415
85. Kimsey, P. B., Theodos, C. M, Mitchen, T. K, Turco, S. J., and Titus, R. G. (1993) An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major. Infect. Immun. 61, 5205-5213
86. Kurtzhals, J. A. L., Hey, A. S, Jardim, A., Kemp, M., Schaefer, K., Oderà, E. O., Christensen, C. B. V., Githure, J. I., Olafson, R. W, Theander, T. G., and Kharazmi, A. (1994) Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Thl-like response to lipophosphoglycan-associated protein protein in cells from cured visceral leishmaniasis patients. Clin. Exp. Immunol. 96, 416-421
87. Laskay, T., Diefenbach, A., Röllinghoff, M., and Solbach, W. (1995) Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25, 2220-2227
88. Laskay, T., Röllinghoff, M., and Solbach, W. (1993) Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 23, 2237-2241
89. Launois, P., Ohteki, T., Swihart, K, MacDonald, H. R., and Louis, J. A. (1995) In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur. J. Immunol. 25, 3298-3307
90. Le Gros, G., Ben-Sasson, S. Z, Seder, R., Finkelman, F. D, and Paul, W. E. (1990) Generation of interleukin-4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 172, 921-929
91. Leiby, D. A., Schreiber, R. D., and Nacy, C. A. (1993) IFN-γ produced in vivo during the first two days is critical for resolution of murine Leishmania major infections. Mircobial Pathog. 14, 495-500
92. Liew, F. Y. and O'Donnell, C. A. (1993) Immunology of leishmaniasis. Adv. Parasitol. 32, 161-259
93. Liew, F. Y., Li, Y., and Millott, S. (1990b) Tumor necrosis factor (TNF-α) in leishmaniasis. II. TNF-α induced macrophage leishmanicidal activity is mediated by nitric oxide from Larginine. Immunology 71, 556-559
94. Liew, F. Y., Li, Y., Moss, D., Parkinson, C., Rogers, M. V., and Moneada, S. (1991) Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21, 3009-3014
95. Liew, F. Y., Millott, S. M., and Schmidt, J. A. (1990) A repetitive peptide of Leishmania can activate T helper type 2 cells and enhance disease progression. J. Exp. Med. 172, 1359-1365
96. Liew, F. Y., Parkinson, C., Millott, S., Severn, A., and Carrier, M. (1990a) Tumor necrosis factor (TNFα) in leishmaniasis. I. TNFα mediates host protection against cutaneous leishmaniasis. Immunol. 69, 570-573
97. Locksley, R. M, Reiner, S. L, Hatam, F., Littman, D. R, and Killeen, N. (1993) Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261, 1448-1451
98. Lohoff, M., Sommer, F., Solbach, W., and Röllinghoff, M. (1989) Coexistence of antigenspecific Thl and Th2 cells in genetically susceptible BALB/c mice infected with Leishmania major. Immunobiology 179, 412-421
99. Lohoff, M., Steinert, M., Weiss, A., Röllinghoff, M., Balderas, R. S., and Theofilopoulos, A. N. (1994) Vβ gene repertoires in T cells expanded in local self-healing and lethal systemic murine cutaneous leishmaniasis. Eur. J. Immunol. 24, 492-495
100. Macatonia, S. E., Hosken, N. A., Litton, M., Vieira, P., Hsieh, C.-S., Culpepper, J. A., Wysocka, M., Trinchieri, G., Murphy, K. M., and O'Garra, A. (1995) Dendritic cells produce IL-12 and direct the development of Thl cells from naive CD4+ T cells. J. Immunol. 154, 5071-5079
101. Macatonia, S. E, Hsieh, C.-S., Murphy, K. M, and O'Garra, A. (1993) Dendritic cells and macrophages are required for Thl development of CD4+ T cells from α β TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γproduction is IFN-γ-dependent. Int. Immunol. 5, 1119-1128
102. MacDonald, R. (1995) NK1.1 + T cell receptor-α/β+ cells: new clues to their origin, specificity, and function. J. Exp. Med. 182, 633-638
103. Magill, A. J., Grögl, M., Gasser Jr., R. A., Sun, W, and Oster, C. N. (1993) Visceral infection caused by Leishmania tropica in veterans of operation desert storm. New Engl. J. Med. 328, 1383-1387
104. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M.-P., Maggi, E., Trinchieri, G., and Romagnani, S. (1993) Natural killer cell stimulatory factor (Interleukin 12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204
105. Mayrink, W., Williams, P., da Costa, C. A., Magalhäes, P. A., Melo, M. A., Dias, M., Lima, A. O., Michalick, M. S. M., Carvalho, E. F., Barros,G. C., Sessa, P. A., and de Alencar, J. T. A. (1985) An experimental vaccine against American dermal leishmaniasis: experience in the State of Espirito Santo, Brazil. Annals Trop. Med. Parasitol. 79, 259-269
106. McConville, M. J., Bacic, A., Mitchell, G. F., and Handman, E. (1987) Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor. Proc. Natl. Acad. Sci. USA 84, 8941-8945
107. McKnight, A. J., Zimmer, G. J., Fogelman, I., Wolf, S. F., and Abbas, A. K. (1994) Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152, 2172-2179
108. McLeod, R., Buschman, E., Arbuckle, L. D., and Skamene, E. (1995) Immunogenetics in the analysis of resistance to intracellular pathogens. Curr. Opin. Immunol. 7, 539-552
109. McMahon-Pratt, D., Rodriguez, D., Rodriguez, J.-R., Zhang, Y., Manson, K., Bergman, C., Rivas, L., Rodriguez, J. F., Lohman, K. L., Ruddle, N. H., and Esteban, M. (1993) Recom binant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. Infect. Immun. 61, 3351-3359
110. Mebrahtu, Y., Lawyer, P., Githure, J., Were, J. B., Muigai, R., Hendricks, L., Leeuwenburg, J., Koech, D., and Clifford, R. (1989) Visceral leishmaniasis unresponsive to pentastam caused by Leishmania tropica in Kenya. Am. J. Trop. Med. Hyg. 41, 289-294
111. Minty, A., Chalón, P., Derocq, J.-M., Dumont, X., Guillemot, J.-C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B, Minty, C., Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P., and Caput, D. (1993) Interleukin 13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362, 248-250
112. Miralles, G. D., Stoeckle, M. Y., McDermott, D. F., Finkelman, F. D, and Murray, H. W. (1994) Thl and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62, 1058-1063
113. Mitchell, G. F. and Handman, E. (1986) The glycoconjugate derived from a Leishmania major receptor for macrophages is a suppressogenic, disease-promoting antigen in murine cutaneous leishmaniasis. Parasite Immunol. 8, 255-263
114. Mitchell, G. F., Handman, E., and Spithill, T. W. (1985) Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major. Int. J. Parasitol. 15, 677-684
115. Modabber, F. (1989) Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitology 98, S49-S60
116. Moll, H. and Röllinghoff, M. (1990) Resistance to murine cutaneous leishmaniasis is mediated by Thl cells, but disease-promoting CD4+ cells are different from Th2 cells. Eur. J. Immunol. 20, 2067-2074
117. Moll, H, Mitchell, G. F., McConville, M. J., and Handman, E. (1989) Evidence that T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infect. Immun. 57, 3349-3356
118. Monjour, L., Monjour, E., Vouldoukis, I., Ogunkolade, B. W., and Frommel, D. (1986) Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer. Lancet i, 1490
119. Monjour, L., Silva, O. A., Vouldoukis, I., Neogy, A. B., Brito, M. E., Filho, S. P., and Jardim, M. L. (1992) Immunoprophylaxis in cutaneous leishmaniasis. Lancet 340, 1098-1099
120. Morris, L., Troutt, A. B., McLeod, K. S., Kelso, A., Handman, E., and Aebischer, T. (1993) Interleukin-4, but not interferon-γ production correlates with the severity of murine cutaneous leishmaniasis. Infect. Immmun. 61, 3459-3465
121. Mosmann, T. R, Cherwinski, H, Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357
122. Mosmann, T. R, Schumacher, J. H, Street, N. F., Budd, R, O'Garra, A., Fong, T. A. T., Mond, M. W., Moore, K. W. M., Sher, A., and Fiorentino, D. F. (1991) Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Reviews 123, 209-229
123. Mougneau, E., Altare, F., Wakil, A. E., Zheng, S., Coppola, T., Wang, Z.-E., Waldmann, R., Locksley, R. M., and Glaichenhaus, N. (1995) Expression cloning of a protective Leishmania antigen. Science 268, 563-566
124. Müller, I. (1992) Role of T cell subsets during the recall of immunologic memory to Leishmania major. Eur. J. Immunol. 22, 3063-3069
125. Müller, I. and Louis, J. A. (1989) Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites. Eur. J. Immun. 19, 865-871
126. Müller, I., Garcia-Sanz, J. A., Titus, R., Behin, R, and Louis, J. (1989) Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite, Leishmania major. Immunol. Reviews 112, 95-113
127. Müller, I., Kropf, P., Etges, R. J., and Louis, J. A. (1993) Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infect. Immun. 61, 3730-3738
128. Müller, I., Pedrazzini, T., Kropf, P., Louis, J., and Milon, G. (1991) Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells. Int. Immunol. 3, 587-597
129. Murray, H. W. and Hariprashad, J. (1995) Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181, 387-391
130. Murray, H. W., Hariprashad, J., and Agüero, B. (1995) Antimicrobial response of a T celldeficient host to cytokine therapy: effect of interferon-γ in experimental visceral leishmaniasis in nude mice. J. Infect. Dis. 171, 1309-1316
131. Murray, H. W., Miralles, G. D, Stoeckle, M. Y, and McDermott, D. F. (1993) Role and effect of interleukin-2 in experimental visceral leishmaniasis. J. Immunol. 151, 929-936
132. Murray, H. W., Rubin, B. Y., Camero, S., and Acosta, A. M. (1984) Reversible defect in antigen-induced lymphokine and g-interferon generation in cutaneous leishmaniasis. J. Immunol. 133, 2250-2254
133. Murray, H. W., Squires, K. E., Miralles, C. D., Stoeckle, M., Granger, A. M., Granelli-Piperno, A., and Bogdan, C. (1992) Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J. Immunol. 148, 1858-1863
134. Nabors, G. S. and Farrell, J. P. (1994) Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect. Immun. 62, 3655-3662
135. Nabors, G. S., Afonso, L. C. C, Farrell, J. P., and Scott, P. (1995) Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania majoñnfection in mice is induced by combined therapy with interleukin 12 and pentostam. Proc. Natl. Acad. Sci. USA 92, 3142-3146
136. Naggan, L., Gunders, A. E., and Mochaeli, D. (1972) Follow-up study of a vaccination programme against cutaneous leishmaniasis. II. Vaccination with a recently isolated strain of L. tropica from Jericho. Trans. Roy. Soc. Trop. Med. Hyg. 66, 239-243
137. Nascimento, E., Mayrink, W., da Costa, C. A., Michalick, M. S. M., Melo, M. N., Barros, G. C., Dias, M., Antunes, C. M. F., Lima, M. S., Taboada, D. C., and Liu, T. Y. (1990) Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses. Infect. Immun. 58, 2198-2203
138. Naume, B. and Espevik, T. (1994) Immunomodulatory effects of cytokines on natural killer cells. Scand. J. Immunol. 40, 128-134
139. Nickol, A. D. and Bonventre, P. F. (1985) Visceral leishmaniasis in congenie mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infect. Immun. 50, 160-168
140. Overath, P. and Harbecke, D. (1993) Course of Leishmania infection in β2-microglobulindeficient mice. Immunol. Letters 37, 13-17
141. Pearson, R. D. and de Queiroz Sousa, A. (1995) Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. In: Mandell, Douglas and Bennett's principles and practice of infectious diseases. Mandell, G. L., Bennett, J. E., and Dolin, R. (eds.). Churchill Livingstone, New York, 2428-2442
142. Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H, Sette, A., and Bottomly, K. (1995) Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181, 1569-1574
143. Pirmez, C., Yamamura, M., Uyemura, K., Paes-Oliveira, M., Conceiçâo-Silva, F., and Modlin, R. L. (1993) Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91, 1390-1395
144. Powrie, F., Correa-Oliveira, R., Mauze, S., and Coffman, R. L. (1994) Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance berween protective and pathogenic cell-mediated immunity. J. Exp. Med. 179, 589-600
145. Preston, P. M. and Dumonde, D. C. (1976) Experimental cutaneous leishmaniasis V. Protective immunity in subclinical and self-healing infection in the mouse. Clin. Exp. Immunol. 23, 126-138
146. Puccetti, P., Romani, L., and Bistoni, F. (1995) A Thl-Th2-like switch in candidiasis: new perspectives for therapy. Trends in Microbiol. 3, 237-240
147. Rachamin, N. and Jaffe, C. L. (1993) Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. J. Immunol. 150, 2322-2331
148. Reiner, N. E. and Finke, J. H. (1983) Interleukin-2 deficiency in murine leishmaniasis and its relationship to depressed spleen cell responses to phytohemagglutinin. J. Immunol. 131, 1487-1491
149. Reiner, N. E., Ng, W., Ma, T., and McMaster, W. R. (1988) Kinetics of γ interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages. Proc. Natl. Acad. Sci. 85, 4330-4334
150. Reiner, S. L. and Locksley, R. M. (1995) The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177
151. Reiner, S. L., Wang, Z.-E., Hatam, F., Scott, P., and Locksley, R. M. (1993) Thl and Th2 cell antigen receptors in experimental leishmaniasis. Science 259, 1457-1460
152. Reiner, S. L., Zheng, S., Wang, Z.-E., Stowring, L., and Locksley, R. M. (1994) Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 179, 447-456
153. Ritter, U., Moll, H., Laskay, T., Bröcker, E.-B., Castrejon, O. V., Becker, I., and Gillitzer, R. (1996) Differential expression of chemokines in skin lesions of patients with localized and diffuse American cutaneous leishmaniasis. J. Infect. Dis. (in press)
154. Roberts, S. C., Wilson, M. E., and Donelson, J. E. (1995) Developmental regulated expression of a novel 59 kDa product of the major surface protease (Msp or gp63) gene family of Leishmania chagasi. J. Biol. Chem. 270, 8884-8892
155. Rodrigues, M. M., Mendonca-Previato, L., Charlab, R., and Barcinski, M. A. (1987) The cellular immune response to a purified antigen from Leishmania mexicana subsp. amazonensis enhances the size of the leishmanial lesion on susceptible mice. Infect. Immun. 55, 3142-3148
156. Romagnani, S. (1994) Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12, 227-257
157. Rossi-Bergmann, B, Müller, I., and Godinho, E. B. (1993) Thl and Th2 T-cell subsets are differentially activated by macrophages and T cells in murine leishmaniasis. Infect. Immun. 1993, 2266-2269
158. Russell, D. G. and Alexander, J. (1988) Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140, 1274-1279
159. Russell, D. G. and Talamas-Rohana, P. (1989) Leishmania and the macrophage: a marriage of inconvenience. Immunol. Today 10, 328-333
160. Russo, D. M., Jardim, A., Carvalho, E. M., Sleath, P. R., Armitage, R. J., Olafson, R. W., and Reed, S. G. (1993) Mapping of human T cell epitopes in Leishmania gp63. J. Immunol. 150, 932-939
161. Sacks, D. L. (1989) Metacyclogenesis in Leishmania promastigotes. Exp. Parasitology 69, 100-103
162. Sacks, D. L, Lai, S. L, Shrivastava, S. N., Blackwell, J., and Neva, F. A. (1987) An analysis of T cell responsiveness in indian kala-azar. J. Immunol. 138, 908-913
163. Sacks, D. L., Pimenta, P. F. P., McConville, M. J., Schneider, P., and Turco, S. J. (1995) Stagespecific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J. Exp. Med. 181, 685-697
164. Sad, S. and Mosmann, T. R. (1994) Single IL-2 secreting precursor CD4 T cell can develop into either Thl or Th2 cytokine secretion phenotype. J. Immunol. 153, 3514-3522
165. Sad, S., Marcotte, R., and Mosmann, T. R. (1995) Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Thl or Th2 cytokines. Immunity 2, 271-279
166. Sadick, M. D, Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., and Locksley, R. M. (1990) Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-y-independent mechanism. J. Exp. Med. 171, 115-127
167. Sadick, M. D., Locksley, R. M., Tubbs, C., and Raff, H. V. (1986) Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-yin response to leishmania antigens in vitro. J. Immunol. 136, 655-661
168. Saha, B., Das, G., Vohra, H, Ganguly, N. K., and Mishra, G. C. (1995) Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implications in the suppression of cell-mediated immunity. Eur. J. Immunol. 25, 2492-2498
169. Scharton, T. M. and Scott, P. (1993) Natural killer cells are a source of I FN-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-578
170. Scharton-Kersten, T., Afonso, L. C. C, Wysocka, M, Trinchieri, G, and Scott, P. (1995) IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154, 5320-5330
171. Schmitt, E., Hoehn, P., Germann, T., and Rüde, E. (1994) Differential effects of interleukin-12 on the development of naive mouse CD4+ T cells. Eur. J. Immunol. 24, 343-347
172. Schmitt, E., Hoehn, P., Huels, C., Goedert, S, Palm, N, Rüde, E. and Germann, T. (1994) T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin 12 and interferon-yand is inhibited by transforming growth factor-β. Eur. J. Immunol. 24, 793-798
173. Schmitz, J., Assenmacher, M. and Radbruch, A. (1993) Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur. J. Immunol. 23, 191-199
174. Schneider, P., Rosat, J. P., Bouvier, J., Louis, J., and Bordier, C. (1992) Leishmania major, differential regulation of the surface metalloprotease in amastigote and promastigote stages. Exp. Parasitol. 75, 196-206
175. Scott, P. (1991) IFN-y modulates the early development of Thl and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147, 3149-3155
176. Scott, P., Pearce, E., Natovitz, P., and Sher, A. (1987) Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and non-protective subfractions of a soluble promastigote extract. J. Immunol. 139, 3118-3125
177. Shankar, A. H. and Titus, R. G. (1995) T cell and Non-T cell compartments can independently determine resistance to Leishmania major. J. Exp. Med. 181, 845-855
178. Sieling, P., Wang, X.-H., Gately, M. K., Oliveros, J. L, McHugh, T., Barnes, P. F., Wolf, S. F., Golkar, L, Yamamira, M., Yogi, Y., Uyemura, K, Rea, T. H., and Modlin, R. L. (1994) IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J. Immunol. 153, 3639-3647
179. Silva, J. S., Twardzik, D. R, and Reed, S. G. (1991) Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J. Exp. Med. 174, 539-545
180. Skeiky, Y. A. W. (1994) 8th International Congress of Parasitology, Izmir, Turkey
181. Skeiky, Y. A. W., Guderian, J. A., Benson, D. R, Bacelar, O., Carvalho, E. M, Kubin, M., Badaro, R., Trinchieri, G., and Reed, S. G. (1995) A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Thl-type cytokine profile and to produce interleukin-12. J. Exp. Med. 181, 1527-1537
182. Soares, L. R. B. and Barcinski, M. A. (1992) Differential production of granulocytemacrophage colony-stimulating factor by macrophages from mice susceptible and resistant to Leishmania mexicana amazonensis. J. Leukocyte Biol. 51, 220-224
183. Soares, L. R. B., Sercarz, E. E., and Miller, A. (1994) Vaccination of the Leishmania major susceptible BALB/c mouse. I. The precise selection of peptide determinant influences CD4+ T cell subset expression. Int. Immunol. 5, 785-794
184. Solbach, W., Lohoff, M., Streck, H., Rohwer, P., and Röllinghoff, M. (1987) Kinetics of cellmediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2. Immunol. 62, 485-492
185. Soong, L., Duboise, M., Kima, P., and McMahon-Pratt, D. (1995) Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63, 3559-3566
186. Spaccapelo, R., Romani, L., Tonnetti, L., Cenci, E., Mencacci, A., Del Sero, G., Tognelli, R., Reed, S. G., Pucetti, P., and Bistoni, F. (1995) TGF-β is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol. 155, 1349-1360
187. Squires, K. E, Schreiber, R. D., McElrath, M. J., Rubin, B. Y., Anderson, S. L., and Murray, H. W. (1989) Experimental visceral leishmaniasis: role of endogenous IFN-γB host defense and tissue granulomatous response. J. Immunol. 143, 4244-4249
188. Steinberger, A., Slutzky, G. M., El-On, J., and Greenblatt, C. L. (1984) Leishmania tropica: protective response in C3H mice vaccinated with excreted factor crosslinked with the synthetic adjuvant, muramyl dipeptide. Exp. Parasitol. 58, 223-229
189. Stenger, S., Thüring, H., Röllinghoff, M., and Bogdan, C. (1994) Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180, 783-793
190. Stern, J. J., Oca, M. J., Rubin, B. Y., Anderson, S. L., and Murray, H. W. (1988) Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis. J. Immunol. 140, 3971-3977
191. Stout, R. D. (1993) Macrophage activation by T cells: cognate and non-cognate signals. Current Opinion in Immunology 5, 398-403
192. Swain, S. L., Weinberg, A. D., English, M. and Huston, G. (1990) IL-4 directs the development of Th2 like helper effectors. J. Immunol. 145, 3796-3806
193. Swain, S., Huston, G., Tonkonogy, S. and Weinberg, A. (1991) Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147, 2991-3000
194. Swihart, K., Fruth, U., Messmer, N., Hug, K., Behin, R., Huang, S., Giudice, G. D., Aguet, M., and Louis, J. A. (1995) Mice from genetically resistant background lacking the interferon-γ receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J. Exp. Med. 181, 961-971
195. Symons, F. M., Murray, P. J., Ji, H., Simpson, R. J., Osnorn, A. H., Cappai, R., and Handman, E. (1994) Characterization of a polymorphic family of integral membrane proteins in promastigotes of different Leishmania species. Mol. Biochem. Parasitol. 67, 103-113
196. Sypek, J. P., Chung, C. L., Mayor, S. H. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., and Schaub, R. G. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802
197. Theodos, C. M., Povinelli, L, Molina, R, Sherry, B, and Titus, R. G. (1991) Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect. Immun. 59, 2839-2842
198. Titus, R. G., Milon, G., Marchai, G., Vassalli, P., Cerottini, J.-C., and Louis, J. A. (1987) Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur. J. Immunol. 17, 1429-1433
199. Titus, R. G., Müller, I., Kimsey, P., Cerny, A., Behin, R., Zinkernagel, R. M., and Louis, J. A. (1991) Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania mayor-specific T cell lines or clones which secrete interferon-γ and mediate parasite-specific delayed-type hypersensitivity. Eur. Immunol. 21, 559-567
200. Titus, R. G., Sherry, B., and Cerami, A. (1989) Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170, 2097-2104
201. Titus, R. D., Gueiros-Filho, E J., de Freitas, L. A. R., and Beverley, S. M. (1995) Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. USA 92, 10267-10271
202. Tobin, J. E., Reiner, S. L., Hatam, F., Zheng, S., Leptak, C. L., Wirth, D. F., and Locksley, R. M. (1993) Transfected Leishmania expressing biologically active IFN-γ. J. Immunol. 150, 5059-5069
203. Trinchieri, G. (1989) Biology of natural killer cells. Adv. Immunol. 47, 187
204. Trinchieri, G. (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027
205. Tripp, C. S., Wolf, S. F., and Unanue, E. R. (1993) Interleukin 12 and tumor necrosis factor a are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90, 3725-3729
206. Turco, S. J. and Descouteaux, A. (1992) The lipophosphoglycans of Leishmania parasites. Annu. Rev. Microbiol. 46, 65-94
207. Uyemura, K., Pirmez, C., Sieling, P. A., Kiene, K., Paes-Oliveira, M., and Modlin, R. L. (1993) CD4+ typel and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. J. Immunol. 151, 7095-7104
208. Vidal, S., Tremblay, M. L., Govoni, G., Gauthier, S., Sebastiani, G., Malo, D., Skamene, E., Olivier, M., Jothy, S., and Gros, P. (1995) The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the NRAMP1 gene. J. Exp. Med. 182, 655-666
209. Vieira, L. Q., Hondowicz, B. D., Afonso, L. C. C., Wysocka, M., Trinchieri, G., and Scott, P. (1994) Infection of Leishmania major induces interleukin 12 production in vivo. Immunol. Letters 40, 157-161
210. Wagner, H. M., Beuscher, H. U., Röllinghoff, M., and Solbach, W. (1991) Interferon-γ inhibits the efficacy of interleukin 1 to generate a Th2-cell biased immune response induced by Leishmania major. Immunobiol. 182, 292-306
211. Wahl, S. M. (1994) Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180, 1587-1590
212. Wang, Z.-E., Reiner, S. L., Hatam, F., Heinzel, F. P., Bouvier, J., Turck, C. W., and Locksley, R. M. (1993) Targeted activation of CD8 cells and infection of β2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J. Immunol. 151, 2077-2086
213. Wang, Z.-E., Reiner, S. L., Zheng, S., Dalton, D. K., and Locksley, R. M. (1994) CD4+ effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J. Exp. Med. 179, 1367-1371
214. Wang, Z.-E., Zheng, S., Corry, D. B, Dalton, D. K, Seder, R. A., Reiner, S. L, and Locksley, R. M. (1994) Interferon-y-independent effects of interleukin-12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA 91, 12932-12936
215. White, A. C. and McMahon-Pratt, D. (1990) Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine. J. Infect. Dis. 161, 1313
216. Wilson, M. E, Young, B. M., Andersen, K. P., Weinstock, J. V., Metwall, A., Ali, K. M., and Donelson, J. E. (1995) A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice. Infect. Immun. 63, 2062-2069
217. Windhagen, A., Scholz, C., Hollsberg, P., Fukaura, H, Sette, A., and Hafler, D. A. (1995) Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2, 373-380
218. Wynn, T. A., Jankovic, D., Hieny, S., Zioncheck, K., Jardieu, P., Cheever, A. W., and Sher, A. (1995) IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154, 3999-4009
219. Xu, D. and Liew, F. Y. (1995) Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84, 173-176
220. Xu, D., McSorley, S. J., Charfield, S. N, Dougan, G., and Liew, F. Y. (1995) Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA-AroD-). Immunology 85, 1-7
221. Yamamura, M., Uyemura, K., Deans, R. J., Weinberg, K., Rea, T. H., Bloom, B. R., and Modlin, R. L. (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254, 277-279
222. Yang, D. M., Fairweather, N., Button, L. L, McMaster, W. R., Kahl, L. P., and Liew, F. Y. (1990) Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145, 2281-2285
223. Yang, D., Rogers, M. V., Brett, S. J., and Liew, F. Y. (1993) Immunological analysis of the zincbinding peptides of surface metalloproteinase (gp63) of Leishmania major. Immunology 78, 582-585
224. Yoshimoto, T. and Paul, W. E. (1994) CD4+, NK1.1+ T cells promptly produce interleukin 4 in response to in vivo challenge with'anti-CD3. J. Exp. Med. 179, 1285-1295
225. Zilberstein, D., Blumenfeld, N., Liveanu, V., Gepstein, A., and Jaffe, C. L. (1991) Growth at acidic pH induces an amastigote stage-specific protein in Leishmania promastigotes. Mol. Biochem. Parasitol. 45, 175-178